TCR as supervisor of technical systems

Our Technical Control Room (TCR) provides continuous supervision of CERN's technical infrastructure. It also serves the inhabitants of CERN's premises as a contact point in case of problems. Every year we initiate eleven thousand recorded corrective interventions; about half subsequent to user phone calls, the other half to automatic alarms. TCR tasks are essentially fourfold: collect and distribute information on abnormal operation states; supervise those technical systems for which we have a mandate; initiate corrective interventions; and perform corrective on-site interventions outside normal working hours. A TCR operator normally has an education corresponding to a French BTS and initially little professional experience. He holds short-term contracts, up to a maximum of six years. This paper outlines TCR tasks and presents some statistical data. It also indicates relations between users, equipment groups, contract firms and the TCR as go-between. Finally, it gives an account of our seven years experience with operator contracts of limited duration

Recommendations for the LHC safety alarm system

A working group was set up to define the LHC safety alarm system, also known as Alarm-of-Level-3-System (AL3S). The mandate asked for recommendations to be elaborated on four items: the overall concept of the AL3S for machine and experiments, the transmission and display of safety alarms, the AL3S during civil engineering construction, and the transition from the present LEP to the final LHC safety alarm system. The members of the working group represented a wide range of interest and experience including the CERN Fire Brigade, safety officers from experiments and machines, and specialists for safety and control systems. The recommendations highlight the need for a clear definition of responsibilities and procedures, well-engineered homogeneous systems across CERN, and they point to several important issues outside the mandate of the working group. These recommendations were presented, discussed and accepted by several CERN and LHC committees

Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth

We aimed to identify novel molecular mechanisms for muscle growth during administration of anabolic agents. Growing pigs (Duroc/(Landrace/Large-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20ppm in feed) or Reporcin (recombinant growth hormone; GH; 10mg/48hours injected) and compared to a control cohort (feed only; no injections) over a 27-day time course (1, 3, 7, 13 or 27-days). Longissimus Dorsi muscle gene expression was analyzed using Agilent porcine transcriptome microarrays and clusters of genes displaying similar expression profiles were identified using a modified maSigPro clustering algorithm. Anabolic agents increased carcass (p=0.002) and muscle weights (Vastus Lateralis: p<0.001; Semitendinosus: p=0.075). Skeletal muscle mRNA expression of serine/one-carbon/glycine biosynthesis pathway genes (Phgdh, Psat1 and Psph) and the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase-M (Pck2/PEPCK-M), increased during treatment with BA, and to a lesser extent GH (p<0.001, treatment x time interaction). Treatment with BA, but not GH, caused a 2-fold increase in phosphoglycerate dehydrogenase (PHGDH) protein expression at days 3 (p<0.05) and 7 (p<0.01), and a 2-fold increase in PEPCK-M protein expression at day 7 (p<0.01). BA treated pigs exhibit a profound increase in expression of PHGDH and PEPCK-M in skeletal muscle, implicating a role for biosynthetic metabolic pathways in muscle growth